VECT
VectivBio Holding AG
NASDAQ: VECT · HEALTHCARE · PHARMACEUTICALS
$16.85
+0.00% today
Updated 2026-04-30
Market cap
$1.06B
P/E ratio
—
P/S ratio
21.08x
EPS (TTM)
$-2.10
Dividend yield
—
52W range
$0 – $0
Volume
—
VectivBio Holding AG (VECT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-294.50%
ROE
-56.90%
ROA
-25.90%
Debt/equity
0.05x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-23.53M | — | — | — |
| 2020 | $0.00 | $-60.50M | — | — | — |
| 2021 | $0.00 | $-87.01M | — | — | — |
| 2022 | $27.34M | $-93.73M | 100.00% | -294.52% | -342.84% |